Abstract | BACKGROUND: AIM: METHODS: We retrospectively analysed data from 86 patients with primary sclerosing cholangitis from eight centres in Italy between 1987 and 1997: 69 were treated with ursodeoxycholic acid (8-13 mg/kg/day), while 17 received symptomatic treatment and served as controls. The effect of therapy was evaluated by standard liver function tests and symptom analysis. RESULTS:
Ursodeoxycholic acid treatment was associated with significant improvement in serum alkaline phosphatase (735+/-833 vs. 519+/-448 U/l, p<0.001), gamma-glutamyl transpeptidase (401+/-352 vs. 234+/-235 U/l, p<0.001), aspartate aminotransferase (87+/-70 vs. 56+/-42 U/l, p=0.001), alanine aminotransferase (146+/-139 vs. 76+/-73 U/l, p<0.001), and total bilirubin (1.88+/-2.44 vs. 1.76+/-4.12 U/l, p=0.01); there was also amelioration of fatigue (p=0.007), jaundice (p=0.002), and body weight loss (p=0.002). CONCLUSIONS:
|
Authors | L Okolicsanyi, M Groppo, A Floreani, A M Morselli-Labate, A G Rusticali, A Battocchia, M Colombo, G Galatola, G Gasbarrini, M Podda, G Ricci, F Rosina, M Zuin |
Journal | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
(Dig Liver Dis)
Vol. 35
Issue 5
Pg. 325-31
(May 2003)
ISSN: 1590-8658 [Print] Netherlands |
PMID | 12846404
(Publication Type: Journal Article, Multicenter Study)
|
Chemical References |
- Cholagogues and Choleretics
- Ursodeoxycholic Acid
|
Topics |
- Adult
- Aged
- Cholagogues and Choleretics
(administration & dosage)
- Cholangitis, Sclerosing
(drug therapy)
- Female
- Humans
- Italy
- Liver Function Tests
- Male
- Middle Aged
- Retrospective Studies
- Treatment Outcome
- Ursodeoxycholic Acid
(administration & dosage)
|